Horizon Therapeutics Shares Jump On Confirmation Of Takeover Talks With Several Large Companies

Horizon Therapeutics Shares Jump On Confirmation Of Takeover Talks With Several Large Companies
  • Horizon Therapeutics Plc HZNP confirmed it's engaged in preliminary talks with Amgen Inc AMGNJanssen Global Service, and Sanofi SA SNY on potential takeover offers for the company. 
  • According to a statement, there is no certainty that an offer for the company will be made. Under Irish law, each possible acquirer has until 5 p.m. New York Time on Jan. 10 to either make an offer or decide not to submit a bid.
  • Also Read: Horizon Therapeutics Does Not Have Meaningful Upside, Analyst Initiating Coverage Says.
  • The Horizon confirmation comes after the WSJ reported that the company is garnering takeover interest from large pharmaceutical companies. 
  • A deal for Horizon would be big. The company had a market value of almost $18 billion as of the close of trading Tuesday and could fetch a price well over $20 billion with a typical takeover premium.
  • Earlier this month, Horizon increased its full-year 2022 net sales guidance to $3.59-$3.61 billion, compared to the previous guidance of $3.53-$3.60 billion.
  • Price Action: HZNP shares are up 31.5% at $103.60 during the premarket session on the last check Wednesday.

Posted In: Briefswhy it's movingBiotechLarge CapM&ANewsHealth CarePre-Market OutlookMoversTrading IdeasGeneral